A defect in ELOVL7 leads to an accumulation of its substrate and could result in increased C36 and C38 phospholipids, in line with our observations and thus supporting the use of 6-OHDA-treated SH-SY5Y cells as an early-PD model. The gene discussed is ELOVL7; the disease is Parkinson disease.